, World Health Organization (WHO), WHO Report on the Global Tobacco Epidemic, 2015.
, Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study, GBD 2015 Risk Factors Collaborators, vol.388, pp.1659-1724, 2015.
Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies, Arch. Intern. Med, vol.160, pp.939-944, 2000. ,
Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review, JAMA, vol.290, pp.86-97, 2003. ,
, Centers for Disease Control and Prevention. Quitting Smoking Among Adults-United States, vol.65, pp.1457-1464, 2000.
Varenicline: a novel pharmacotherapy for smoking cessation, Drugs, vol.69, pp.1319-1357, 2009. ,
Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice, Br. J. Clin. Pharmacol, vol.77, pp.324-336, 2014. ,
Statins Reduce the Risks of Relapse to Addiction in Rats, Neuropsychopharmacology, vol.41, pp.1588-1597, 2016. ,
Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings, Neuropsychopharmacology, vol.37, pp.1838-1847, 2012. ,
Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence, Nicotine Tob. Res, vol.18, pp.74-78, 2016. ,
The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?, Alcohol. Clin. Exp. Res, vol.41, 1986. ,
The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But not of Anti-Craving Effects, Neuropsychopharmacology, vol.41, pp.2818-2829, 2016. ,
In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, Pharm. Res, vol.11, pp.305-311, 1994. ,
Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death, J. Alzheimers Dis, vol.23, pp.307-318, 2011. ,
Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over ("n-of-1") exploratory trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients, Parkinsonism Relat. Disord, vol.19, pp.416-421, 2013. ,
Individual behavioural counselling for smoking cessation, Cochrane Database Syst. Rev, vol.3, p.1292, 2017. ,
Study protocol for a non-inferiority trial of a blended smoking cessation treatment versus face-to-face treatment (LiveSmokefree-Study), BMC Public Health, vol.16, p.1187, 2016. ,
Bupropion and naltrexone for smoking cessation: A double-blind randomized placebo-controlled clinical trial, Clin. Pharmacol. Ther, vol.100, pp.344-352, 2016. ,
Pharmacological interventions for smoking cessation: an overview and network meta-analysis, Cochrane Database Syst. Rev, vol.5, p.9329, 2013. ,
Pharmacological treatments for smoking cessation, JAMA, vol.311, pp.193-194, 2014. ,
Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data, BMJ, vol.353, p.3283, 2016. ,
Interpretation of the evidence for the efficacy and safety of statin therapy, Lancet, vol.388, pp.2532-2561, 2016. ,
, Institut national de prévention et d' éducation pour la santé. J'arrête de fumer. Le guide pratique pour y parvenir
Arrêt de la consommation de tabac: du dépistage individuel au maintien de l'abstinence en premier recours. Méthode recommandations pour la pratique clinique Argumentaire scientifique, 2013. ,
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire, Br. J. Addict, vol.86, pp.1119-1127, 1991. ,
Multivariate models for predicting abstention following intervention to stop smoking by general practitioners, Addiction, vol.88, pp.1127-1135, 1993. ,
Validity of the 12-item French version of the Tobacco Craving Questionnaire in treatment-seeking smokers, Nicotine Tob. Res, vol.12, pp.500-507, 2010. ,
Nicotine replacement therapy for smoking cessation, Cochrane Database Syst. Rev, vol.11, p.146, 2012. ,